Ambalal Sarabhai Enterprises Limited (BOM:500009)

Market Cap	1.94B -49.6%
Revenue (ttm)	2.03B +8.7%
Net Income	104.58M -22.5%
EPS	1.36 -22.9%
Shares Out	76.63M
PE Ratio	18.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	207,532
Average Volume	92,573
Open	25.50
Previous Close	24.95
Day's Range	24.70 - 25.75
52-Week Range	23.12 - 42.05
Beta	-0.23
RSI	41.92
Earnings Date	Feb 12, 2026

About BOM:500009

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Am...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 104
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500009

Financial Performance

In fiscal year 2025, BOM:500009's revenue was 1.97 billion, an increase of 13.20% compared to the previous year's 1.74 billion. Earnings were 49.31 million, a decrease of -13.20%.